

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.34260230 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.34260230 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.06576265 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.06576265 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.41870408 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.36265543 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 4.94257869 |
| 8 | glyoxylate metabolic process (GO:0046487) | 4.92827631 |
| 9 | epoxygenase P450 pathway (GO:0019373) | 4.78767527 |
| 10 | bile acid biosynthetic process (GO:0006699) | 4.77726452 |
| 11 | cysteine metabolic process (GO:0006534) | 4.68111461 |
| 12 | high-density lipoprotein particle remodeling (GO:0034375) | 4.61595057 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 4.53159823 |
| 14 | tryptophan catabolic process (GO:0006569) | 4.53159823 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 4.53159823 |
| 16 | regulation of cholesterol esterification (GO:0010872) | 4.50537202 |
| 17 | alkaloid metabolic process (GO:0009820) | 4.48053847 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 4.45622424 |
| 19 | coenzyme catabolic process (GO:0009109) | 4.38726084 |
| 20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.34339531 |
| 21 | kynurenine metabolic process (GO:0070189) | 4.31610199 |
| 22 | urea metabolic process (GO:0019627) | 4.31472526 |
| 23 | urea cycle (GO:0000050) | 4.31472526 |
| 24 | reverse cholesterol transport (GO:0043691) | 4.27097801 |
| 25 | tryptophan metabolic process (GO:0006568) | 4.27091657 |
| 26 | omega-hydroxylase P450 pathway (GO:0097267) | 4.24285500 |
| 27 | cellular ketone body metabolic process (GO:0046950) | 4.18849472 |
| 28 | regulation of triglyceride catabolic process (GO:0010896) | 4.17505576 |
| 29 | plasma lipoprotein particle remodeling (GO:0034369) | 4.06735927 |
| 30 | protein-lipid complex remodeling (GO:0034368) | 4.06735927 |
| 31 | macromolecular complex remodeling (GO:0034367) | 4.06735927 |
| 32 | phospholipid efflux (GO:0033700) | 4.03541645 |
| 33 | protein carboxylation (GO:0018214) | 4.02266229 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.02266229 |
| 35 | drug metabolic process (GO:0017144) | 4.00990572 |
| 36 | nitrogen cycle metabolic process (GO:0071941) | 4.00473376 |
| 37 | oxidative demethylation (GO:0070989) | 3.99811813 |
| 38 | negative regulation of fibrinolysis (GO:0051918) | 3.99229184 |
| 39 | bile acid metabolic process (GO:0008206) | 3.98255968 |
| 40 | lysine catabolic process (GO:0006554) | 3.93367044 |
| 41 | lysine metabolic process (GO:0006553) | 3.93367044 |
| 42 | aromatic amino acid family metabolic process (GO:0009072) | 3.87136973 |
| 43 | regulation of protein activation cascade (GO:2000257) | 3.86855108 |
| 44 | aldehyde catabolic process (GO:0046185) | 3.85448280 |
| 45 | regulation of fibrinolysis (GO:0051917) | 3.82244335 |
| 46 | homocysteine metabolic process (GO:0050667) | 3.80493073 |
| 47 | cholesterol efflux (GO:0033344) | 3.79584846 |
| 48 | tyrosine metabolic process (GO:0006570) | 3.79034919 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 3.78692642 |
| 50 | cofactor catabolic process (GO:0051187) | 3.77666709 |
| 51 | alpha-amino acid catabolic process (GO:1901606) | 3.77029022 |
| 52 | cellular glucuronidation (GO:0052695) | 3.71976502 |
| 53 | complement activation, alternative pathway (GO:0006957) | 3.70547298 |
| 54 | low-density lipoprotein particle remodeling (GO:0034374) | 3.69507578 |
| 55 | quinone biosynthetic process (GO:1901663) | 3.68672742 |
| 56 | glutamate metabolic process (GO:0006536) | 3.68415649 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 3.67594123 |
| 58 | negative regulation of sterol transport (GO:0032372) | 3.67594123 |
| 59 | drug catabolic process (GO:0042737) | 3.65767672 |
| 60 | regulation of complement activation (GO:0030449) | 3.63961426 |
| 61 | cellular modified amino acid catabolic process (GO:0042219) | 3.62882167 |
| 62 | intestinal cholesterol absorption (GO:0030299) | 3.62817145 |
| 63 | arginine catabolic process (GO:0006527) | 3.62113002 |
| 64 | ketone body metabolic process (GO:1902224) | 3.62007957 |
| 65 | serine family amino acid catabolic process (GO:0009071) | 3.60739059 |
| 66 | cellular amino acid catabolic process (GO:0009063) | 3.60226195 |
| 67 | glucuronate metabolic process (GO:0019585) | 3.54944451 |
| 68 | uronic acid metabolic process (GO:0006063) | 3.54944451 |
| 69 | very long-chain fatty acid metabolic process (GO:0000038) | 3.53737981 |
| 70 | aspartate family amino acid catabolic process (GO:0009068) | 3.52949510 |
| 71 | flavonoid metabolic process (GO:0009812) | 3.52784363 |
| 72 | arginine metabolic process (GO:0006525) | 3.46056053 |
| 73 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.42502972 |
| 74 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.42502972 |
| 75 | plasma lipoprotein particle clearance (GO:0034381) | 3.42125455 |
| 76 | ethanol oxidation (GO:0006069) | 3.41751539 |
| 77 | triglyceride homeostasis (GO:0070328) | 3.40768071 |
| 78 | acylglycerol homeostasis (GO:0055090) | 3.40768071 |
| 79 | short-chain fatty acid metabolic process (GO:0046459) | 3.40090562 |
| 80 | platelet dense granule organization (GO:0060155) | 3.38385012 |
| 81 | plasma lipoprotein particle assembly (GO:0034377) | 3.33907376 |
| 82 | ubiquinone biosynthetic process (GO:0006744) | 3.32426243 |
| 83 | bile acid and bile salt transport (GO:0015721) | 3.30758913 |
| 84 | ethanol metabolic process (GO:0006067) | 3.29019610 |
| 85 | regulation of plasminogen activation (GO:0010755) | 3.28292288 |
| 86 | acetyl-CoA metabolic process (GO:0006084) | 3.27938217 |
| 87 | amine catabolic process (GO:0009310) | 3.26609548 |
| 88 | cellular biogenic amine catabolic process (GO:0042402) | 3.26609548 |
| 89 | serine family amino acid biosynthetic process (GO:0009070) | 3.26491486 |
| 90 | organic acid catabolic process (GO:0016054) | 3.25970266 |
| 91 | carboxylic acid catabolic process (GO:0046395) | 3.25970266 |
| 92 | blood coagulation, intrinsic pathway (GO:0007597) | 3.25746599 |
| 93 | quinone metabolic process (GO:1901661) | 3.24183831 |
| 94 | benzene-containing compound metabolic process (GO:0042537) | 3.24007265 |
| 95 | DNA deamination (GO:0045006) | 3.23604354 |
| 96 | response to nitrosative stress (GO:0051409) | 3.21904627 |
| 97 | S-adenosylmethionine metabolic process (GO:0046500) | 3.21188138 |
| 98 | serine family amino acid metabolic process (GO:0009069) | 3.21151020 |
| 99 | indolalkylamine metabolic process (GO:0006586) | 3.21022330 |
| 100 | drug transmembrane transport (GO:0006855) | 3.19831475 |
| 101 | fatty acid elongation (GO:0030497) | 3.18614637 |
| 102 | monocarboxylic acid catabolic process (GO:0072329) | 3.16800164 |
| 103 | exogenous drug catabolic process (GO:0042738) | 3.16655745 |
| 104 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.15926198 |
| 105 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.15926198 |
| 106 | cholesterol homeostasis (GO:0042632) | 3.14211235 |
| 107 | negative regulation of protein activation cascade (GO:2000258) | 3.13936262 |
| 108 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.13092340 |
| 109 | fatty acid catabolic process (GO:0009062) | 3.12464969 |
| 110 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.10259671 |
| 111 | plasma lipoprotein particle organization (GO:0071827) | 3.09949341 |
| 112 | sterol homeostasis (GO:0055092) | 3.08325820 |
| 113 | regulation of cholesterol metabolic process (GO:0090181) | 3.07299186 |
| 114 | fibrinolysis (GO:0042730) | 3.06416986 |
| 115 | dicarboxylic acid catabolic process (GO:0043649) | 3.06370729 |
| 116 | fatty acid beta-oxidation (GO:0006635) | 3.06209622 |
| 117 | protein-lipid complex assembly (GO:0065005) | 3.05105960 |
| 118 | ubiquinone metabolic process (GO:0006743) | 3.03494500 |
| 119 | xenobiotic catabolic process (GO:0042178) | 3.01578869 |
| 120 | phenylpropanoid metabolic process (GO:0009698) | 2.99678606 |
| 121 | sulfation (GO:0051923) | 2.93517674 |
| 122 | behavioral response to nicotine (GO:0035095) | 2.85183937 |
| 123 | protein activation cascade (GO:0072376) | 2.84249221 |
| 124 | protein-cofactor linkage (GO:0018065) | 2.80584319 |
| 125 | regulation of humoral immune response (GO:0002920) | 2.76356190 |
| 126 | protein complex biogenesis (GO:0070271) | 2.74043718 |
| 127 | negative regulation of hemostasis (GO:1900047) | 2.72363925 |
| 128 | negative regulation of blood coagulation (GO:0030195) | 2.72363925 |
| 129 | xenobiotic metabolic process (GO:0006805) | 2.66100670 |
| 130 | imidazole-containing compound metabolic process (GO:0052803) | 2.64304584 |
| 131 | glycine metabolic process (GO:0006544) | 2.62443138 |
| 132 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.62188857 |
| 133 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.62020168 |
| 134 | complement activation (GO:0006956) | 2.59793921 |
| 135 | negative regulation of coagulation (GO:0050819) | 2.59752436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.52141941 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.88993031 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.91262925 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.64467618 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.55277256 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.98058628 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.96279952 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.94772687 |
| 9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.58217039 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.25265876 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.88040694 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.68513343 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.58311128 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.52042455 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.33305264 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.18547774 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 2.04681182 |
| 18 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.91806646 |
| 19 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.80835982 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.75841237 |
| 21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.71173930 |
| 22 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.68845225 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.67736485 |
| 24 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.66499458 |
| 25 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.64439276 |
| 26 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.62539873 |
| 27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59168526 |
| 28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.57053795 |
| 29 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.56635612 |
| 30 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.52636712 |
| 31 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.52078717 |
| 32 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.49653335 |
| 33 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.49653335 |
| 34 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.49027630 |
| 35 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.46390789 |
| 36 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.45942783 |
| 37 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.45214333 |
| 38 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.44666480 |
| 39 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.44532386 |
| 40 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.44194419 |
| 41 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.41855464 |
| 42 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41003817 |
| 43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.38611302 |
| 44 | ERA_21632823_ChIP-Seq_H3396_Human | 1.36305189 |
| 45 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.34281147 |
| 46 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.31934268 |
| 47 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.30480118 |
| 48 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.28912837 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27677536 |
| 50 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.27462175 |
| 51 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.26667199 |
| 52 | P300_27268052_Chip-Seq_Bcells_Human | 1.24621154 |
| 53 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.24234077 |
| 54 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.23781820 |
| 55 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.22319119 |
| 56 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.19852322 |
| 57 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.19624057 |
| 58 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.19556604 |
| 59 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.18659253 |
| 60 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18650201 |
| 61 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18650201 |
| 62 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.18614090 |
| 63 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.18268904 |
| 64 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.15584553 |
| 65 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.14640232 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13955427 |
| 67 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.13238224 |
| 68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12162009 |
| 69 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.12063271 |
| 70 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.11652373 |
| 71 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.11421757 |
| 72 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.11098060 |
| 73 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.09396158 |
| 74 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09145038 |
| 75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08795404 |
| 76 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.08452620 |
| 77 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.06883323 |
| 78 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.05579249 |
| 79 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05075979 |
| 80 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.04344669 |
| 81 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.03284397 |
| 82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02419697 |
| 83 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.02411339 |
| 84 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01874631 |
| 85 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.01350327 |
| 86 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.01077610 |
| 87 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.00225967 |
| 88 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.99878095 |
| 89 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99277043 |
| 90 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.99110403 |
| 91 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.98543128 |
| 92 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98240487 |
| 93 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.97566744 |
| 94 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.97289929 |
| 95 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.96778079 |
| 96 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96128716 |
| 97 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96104652 |
| 98 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.95845920 |
| 99 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95763422 |
| 100 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.95137955 |
| 101 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.93637079 |
| 102 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93337508 |
| 103 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91477575 |
| 104 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90390748 |
| 105 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90113114 |
| 106 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.90106421 |
| 107 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89907568 |
| 108 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.89548608 |
| 109 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88803397 |
| 110 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.88403834 |
| 111 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88189747 |
| 112 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.86703183 |
| 113 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86208099 |
| 114 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.86072346 |
| 115 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86027707 |
| 116 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84334113 |
| 117 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.84000941 |
| 118 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.83747884 |
| 119 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83172695 |
| 120 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.82512217 |
| 121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81764255 |
| 122 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81637066 |
| 123 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81380495 |
| 124 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.80577393 |
| 125 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.78476550 |
| 126 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.76933463 |
| 127 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.76540688 |
| 128 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.76144607 |
| 129 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.75507836 |
| 130 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74088551 |
| 131 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.73582995 |
| 132 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.71958405 |
| 133 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.71937836 |
| 134 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.71269422 |
| 135 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.70474823 |
| 136 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69398753 |
| 137 | * ERG_20517297_ChIP-Seq_VCAP_Human | 0.68427367 |
| 138 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.68211566 |
| 139 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.68211566 |
| 140 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.68183442 |
| 141 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.68183442 |
| 142 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.67857016 |
| 143 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.67830960 |
| 144 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.67287878 |
| 145 | P300_19829295_ChIP-Seq_ESCs_Human | 0.67101080 |
| 146 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.66784754 |
| 147 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.66085611 |
| 148 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.65350836 |
| 149 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.62178134 |
| 150 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.61730307 |
| 151 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.61612036 |
| 152 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.60488295 |
| 153 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.60314523 |
| 154 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.59980220 |
| 155 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.59411728 |
| 156 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.59273832 |
| 157 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.59192759 |
| 158 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.58901544 |
| 159 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.58717828 |
| 160 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.58452751 |
| 161 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.58257613 |
| 162 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.58132636 |
| 163 | CBP_21632823_ChIP-Seq_H3396_Human | 0.57687020 |
| 164 | AR_25329375_ChIP-Seq_VCAP_Human | 0.57589591 |
| 165 | NCOR_22424771_ChIP-Seq_293T_Human | 0.57506995 |
| 166 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.57361384 |
| 167 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.57048391 |
| 168 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.56540179 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.06534745 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.89051690 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.16813178 |
| 4 | MP0005365_abnormal_bile_salt | 5.07151725 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.72007074 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.00932558 |
| 7 | MP0009840_abnormal_foam_cell | 3.26912283 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.07601830 |
| 9 | MP0003252_abnormal_bile_duct | 3.04466257 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.95578579 |
| 11 | MP0005083_abnormal_biliary_tract | 2.84802987 |
| 12 | MP0005332_abnormal_amino_acid | 2.81388131 |
| 13 | MP0003195_calcinosis | 2.41519022 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.09696439 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.04827848 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 1.93067498 |
| 17 | MP0003011_delayed_dark_adaptation | 1.84409434 |
| 18 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.68170005 |
| 19 | MP0005451_abnormal_body_composition | 1.63302953 |
| 20 | MP0003329_amyloid_beta_deposits | 1.62072029 |
| 21 | MP0003690_abnormal_glial_cell | 1.59180350 |
| 22 | MP0000609_abnormal_liver_physiology | 1.58474603 |
| 23 | MP0003186_abnormal_redox_activity | 1.58433832 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.56961691 |
| 25 | MP0000604_amyloidosis | 1.53785043 |
| 26 | MP0009697_abnormal_copulation | 1.52160801 |
| 27 | MP0002132_abnormal_respiratory_system | 1.50762934 |
| 28 | MP0003868_abnormal_feces_composition | 1.49030944 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.48694747 |
| 30 | MP0001764_abnormal_homeostasis | 1.40170273 |
| 31 | MP0009785_altered_susceptibility_to | 1.38707136 |
| 32 | MP0005551_abnormal_eye_electrophysiolog | 1.31291063 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.29409613 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 1.27592579 |
| 35 | MP0004858_abnormal_nervous_system | 1.24568604 |
| 36 | MP0006082_CNS_inflammation | 1.24143373 |
| 37 | MP0005084_abnormal_gallbladder_morpholo | 1.24012952 |
| 38 | MP0002876_abnormal_thyroid_physiology | 1.23094421 |
| 39 | MP0002653_abnormal_ependyma_morphology | 1.21339046 |
| 40 | MP0005377_hearing/vestibular/ear_phenot | 1.17619252 |
| 41 | MP0003878_abnormal_ear_physiology | 1.17619252 |
| 42 | MP0005670_abnormal_white_adipose | 1.16920045 |
| 43 | MP0005636_abnormal_mineral_homeostasis | 1.16904869 |
| 44 | MP0008995_early_reproductive_senescence | 1.16052404 |
| 45 | MP0000685_abnormal_immune_system | 1.15764138 |
| 46 | MP0005671_abnormal_response_to | 1.13754224 |
| 47 | MP0001873_stomach_inflammation | 1.11351366 |
| 48 | MP0003724_increased_susceptibility_to | 1.08226664 |
| 49 | MP0006036_abnormal_mitochondrial_physio | 1.06100853 |
| 50 | MP0001800_abnormal_humoral_immune | 1.06054731 |
| 51 | MP0001835_abnormal_antigen_presentation | 1.05928697 |
| 52 | MP0002822_catalepsy | 1.05698402 |
| 53 | MP0002736_abnormal_nociception_after | 1.01897333 |
| 54 | MP0009764_decreased_sensitivity_to | 1.01562694 |
| 55 | MP0004142_abnormal_muscle_tone | 1.00125252 |
| 56 | MP0006054_spinal_hemorrhage | 0.99565118 |
| 57 | MP0002234_abnormal_pharynx_morphology | 0.96780771 |
| 58 | MP0000516_abnormal_urinary_system | 0.95223901 |
| 59 | MP0005367_renal/urinary_system_phenotyp | 0.95223901 |
| 60 | MP0000427_abnormal_hair_cycle | 0.94085085 |
| 61 | MP0000920_abnormal_myelination | 0.92980628 |
| 62 | MP0005025_abnormal_response_to | 0.92871766 |
| 63 | MP0003436_decreased_susceptibility_to | 0.91413544 |
| 64 | MP0002148_abnormal_hypersensitivity_rea | 0.91341326 |
| 65 | MP0002254_reproductive_system_inflammat | 0.89076086 |
| 66 | MP0005408_hypopigmentation | 0.88988507 |
| 67 | MP0005647_abnormal_sex_gland | 0.88468681 |
| 68 | MP0009333_abnormal_splenocyte_physiolog | 0.86779005 |
| 69 | MP0005387_immune_system_phenotype | 0.84254950 |
| 70 | MP0001790_abnormal_immune_system | 0.84254950 |
| 71 | MP0005645_abnormal_hypothalamus_physiol | 0.83803815 |
| 72 | MP0002837_dystrophic_cardiac_calcinosis | 0.83561489 |
| 73 | MP0002735_abnormal_chemical_nociception | 0.82824563 |
| 74 | MP0002638_abnormal_pupillary_reflex | 0.82331933 |
| 75 | MP0001968_abnormal_touch/_nociception | 0.82146627 |
| 76 | MP0005535_abnormal_body_temperature | 0.81826636 |
| 77 | MP0001845_abnormal_inflammatory_respons | 0.81414207 |
| 78 | MP0003172_abnormal_lysosome_physiology | 0.79398698 |
| 79 | MP0002419_abnormal_innate_immunity | 0.78856843 |
| 80 | MP0008872_abnormal_physiological_respon | 0.78718736 |
| 81 | MP0001984_abnormal_olfaction | 0.78223313 |
| 82 | MP0004043_abnormal_pH_regulation | 0.78022796 |
| 83 | MP0002723_abnormal_immune_serum | 0.76279220 |
| 84 | MP0004270_analgesia | 0.75663395 |
| 85 | MP0005410_abnormal_fertilization | 0.75489227 |
| 86 | MP0000598_abnormal_liver_morphology | 0.74911638 |
| 87 | MP0009642_abnormal_blood_homeostasis | 0.74828354 |
| 88 | MP0005646_abnormal_pituitary_gland | 0.74378954 |
| 89 | MP0001756_abnormal_urination | 0.74051238 |
| 90 | MP0010155_abnormal_intestine_physiology | 0.74043088 |
| 91 | MP0002452_abnormal_antigen_presenting | 0.73746397 |
| 92 | MP0004147_increased_porphyrin_level | 0.73524308 |
| 93 | MP0003075_altered_response_to | 0.69457102 |
| 94 | MP0002282_abnormal_trachea_morphology | 0.69149793 |
| 95 | MP0005000_abnormal_immune_tolerance | 0.68954283 |
| 96 | MP0005376_homeostasis/metabolism_phenot | 0.68573881 |
| 97 | MP0002933_joint_inflammation | 0.68371176 |
| 98 | MP0003638_abnormal_response/metabolism_ | 0.68220963 |
| 99 | MP0005075_abnormal_melanosome_morpholog | 0.68102738 |
| 100 | MP0006292_abnormal_olfactory_placode | 0.67110547 |
| 101 | MP0005464_abnormal_platelet_physiology | 0.66042825 |
| 102 | MP0005448_abnormal_energy_balance | 0.65593927 |
| 103 | MP0001501_abnormal_sleep_pattern | 0.65454789 |
| 104 | MP0009763_increased_sensitivity_to | 0.64999567 |
| 105 | MP0005058_abnormal_lysosome_morphology | 0.64834734 |
| 106 | MP0001663_abnormal_digestive_system | 0.64647202 |
| 107 | MP0002078_abnormal_glucose_homeostasis | 0.64221088 |
| 108 | MP0001905_abnormal_dopamine_level | 0.63804886 |
| 109 | MP0005166_decreased_susceptibility_to | 0.63780950 |
| 110 | MP0009384_cardiac_valve_regurgitation | 0.63732409 |
| 111 | MP0000639_abnormal_adrenal_gland | 0.63292666 |
| 112 | MP0008469_abnormal_protein_level | 0.63144849 |
| 113 | MP0000372_irregular_coat_pigmentation | 0.62570724 |
| 114 | MP0009765_abnormal_xenobiotic_induced | 0.62362210 |
| 115 | MP0001529_abnormal_vocalization | 0.61699700 |
| 116 | MP0003633_abnormal_nervous_system | 0.61572631 |
| 117 | MP0008874_decreased_physiological_sensi | 0.61215654 |
| 118 | MP0003705_abnormal_hypodermis_morpholog | 0.59491379 |
| 119 | MP0002733_abnormal_thermal_nociception | 0.58989962 |
| 120 | MP0006276_abnormal_autonomic_nervous | 0.56739955 |
| 121 | MP0000538_abnormal_urinary_bladder | 0.55855888 |
| 122 | MP0002734_abnormal_mechanical_nocicepti | 0.54483255 |
| 123 | MP0002064_seizures | 0.54475804 |
| 124 | MP0004885_abnormal_endolymph | 0.54424085 |
| 125 | MP0006035_abnormal_mitochondrial_morpho | 0.54368760 |
| 126 | MP0005167_abnormal_blood-brain_barrier | 0.53663114 |
| 127 | MP0000230_abnormal_systemic_arterial | 0.53507006 |
| 128 | MP0009780_abnormal_chondrocyte_physiolo | 0.53046597 |
| 129 | MP0001986_abnormal_taste_sensitivity | 0.52609184 |
| 130 | MP0003631_nervous_system_phenotype | 0.52265039 |
| 131 | MP0001765_abnormal_ion_homeostasis | 0.52115808 |
| 132 | MP0003634_abnormal_glial_cell | 0.51693295 |
| 133 | MP0005334_abnormal_fat_pad | 0.51614901 |
| 134 | MP0002090_abnormal_vision | 0.50903331 |
| 135 | MP0003183_abnormal_peptide_metabolism | 0.50520332 |
| 136 | MP0002295_abnormal_pulmonary_circulatio | 0.49610137 |
| 137 | MP0005395_other_phenotype | 0.49177404 |
| 138 | MP0005165_increased_susceptibility_to | 0.48306509 |
| 139 | MP0004130_abnormal_muscle_cell | 0.47577713 |
| 140 | MP0002136_abnormal_kidney_physiology | 0.47447703 |
| 141 | MP0009745_abnormal_behavioral_response | 0.46161310 |
| 142 | MP0005220_abnormal_exocrine_pancreas | 0.46120784 |
| 143 | MP0003632_abnormal_nervous_system | 0.45752015 |
| 144 | MP0004883_abnormal_blood_vessel | 0.45204143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.18287387 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.67430506 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.61537604 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 5.28256129 |
| 5 | Xanthomatosis (HP:0000991) | 5.18965032 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.97177861 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.60242590 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.31435073 |
| 9 | Hyperammonemia (HP:0001987) | 4.04909099 |
| 10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.96118982 |
| 11 | Hypolipoproteinemia (HP:0010981) | 3.90283863 |
| 12 | Ketosis (HP:0001946) | 3.78794911 |
| 13 | Complement deficiency (HP:0004431) | 3.78696198 |
| 14 | Fat malabsorption (HP:0002630) | 3.72682883 |
| 15 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.58339717 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 3.58086178 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.58086178 |
| 18 | Hyperglycinuria (HP:0003108) | 3.54533917 |
| 19 | Hyperglycinemia (HP:0002154) | 3.48632144 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.47426491 |
| 21 | Conjugated hyperbilirubinemia (HP:0002908) | 3.44902558 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.39402478 |
| 23 | Epidermoid cyst (HP:0200040) | 3.27109762 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 3.26549311 |
| 25 | Abnormal gallbladder physiology (HP:0012438) | 3.24298124 |
| 26 | Cholecystitis (HP:0001082) | 3.24298124 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.23963807 |
| 28 | Abnormality of the common coagulation pathway (HP:0010990) | 3.14440911 |
| 29 | Cerebral edema (HP:0002181) | 3.13023818 |
| 30 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.12077072 |
| 31 | Joint hemorrhage (HP:0005261) | 3.08735870 |
| 32 | Ketoacidosis (HP:0001993) | 3.07129538 |
| 33 | Hypoglycemic coma (HP:0001325) | 2.98879000 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.91860139 |
| 35 | Steatorrhea (HP:0002570) | 2.90954421 |
| 36 | Abnormality of glycolysis (HP:0004366) | 2.89307103 |
| 37 | Increased serum pyruvate (HP:0003542) | 2.89307103 |
| 38 | Lethargy (HP:0001254) | 2.87112513 |
| 39 | Acute encephalopathy (HP:0006846) | 2.85068614 |
| 40 | Delayed CNS myelination (HP:0002188) | 2.84932824 |
| 41 | Glomerulonephritis (HP:0000099) | 2.78190646 |
| 42 | Metabolic acidosis (HP:0001942) | 2.77614266 |
| 43 | Abnormality of alanine metabolism (HP:0010916) | 2.76058615 |
| 44 | Hyperalaninemia (HP:0003348) | 2.76058615 |
| 45 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.76058615 |
| 46 | Hypercholesterolemia (HP:0003124) | 2.71029858 |
| 47 | Gout (HP:0001997) | 2.69709610 |
| 48 | Hyperbilirubinemia (HP:0002904) | 2.67136938 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.66097595 |
| 50 | Congenital, generalized hypertrichosis (HP:0004540) | 2.64842647 |
| 51 | Abnormality of complement system (HP:0005339) | 2.64668228 |
| 52 | Pancreatic cysts (HP:0001737) | 2.63315148 |
| 53 | True hermaphroditism (HP:0010459) | 2.62868145 |
| 54 | Abnormality of the intrinsic pathway (HP:0010989) | 2.56130624 |
| 55 | Dry hair (HP:0011359) | 2.53926308 |
| 56 | Abnormality of nucleobase metabolism (HP:0010932) | 2.53129078 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.52941018 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.52941018 |
| 59 | Sensorimotor neuropathy (HP:0007141) | 2.52368034 |
| 60 | Abnormal gallbladder morphology (HP:0012437) | 2.46661595 |
| 61 | Abnormality of serum amino acid levels (HP:0003112) | 2.45313476 |
| 62 | Congenital stationary night blindness (HP:0007642) | 2.44440798 |
| 63 | Vascular calcification (HP:0004934) | 2.43853571 |
| 64 | Cholelithiasis (HP:0001081) | 2.42645216 |
| 65 | Malnutrition (HP:0004395) | 2.41841715 |
| 66 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.41267870 |
| 67 | Nephritis (HP:0000123) | 2.38305086 |
| 68 | Systemic lupus erythematosus (HP:0002725) | 2.37147368 |
| 69 | Abnormal biliary tract physiology (HP:0012439) | 2.36161100 |
| 70 | Bile duct proliferation (HP:0001408) | 2.36161100 |
| 71 | Vomiting (HP:0002013) | 2.35585216 |
| 72 | Amyloidosis (HP:0011034) | 2.33016983 |
| 73 | Fair hair (HP:0002286) | 2.30250914 |
| 74 | Neurofibrillary tangles (HP:0002185) | 2.29723108 |
| 75 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.28998377 |
| 76 | Hepatic necrosis (HP:0002605) | 2.28101571 |
| 77 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.27192044 |
| 78 | Molar tooth sign on MRI (HP:0002419) | 2.25882185 |
| 79 | Abnormality of midbrain morphology (HP:0002418) | 2.25882185 |
| 80 | Acute necrotizing encephalopathy (HP:0006965) | 2.25555689 |
| 81 | Acanthocytosis (HP:0001927) | 2.23411367 |
| 82 | Pancreatic fibrosis (HP:0100732) | 2.22040000 |
| 83 | Increased CSF lactate (HP:0002490) | 2.21003125 |
| 84 | Irritability (HP:0000737) | 2.18956211 |
| 85 | Pheochromocytoma (HP:0002666) | 2.18896992 |
| 86 | Gangrene (HP:0100758) | 2.18715289 |
| 87 | Glycosuria (HP:0003076) | 2.15611582 |
| 88 | Abnormality of urine glucose concentration (HP:0011016) | 2.15611582 |
| 89 | Cardiovascular calcification (HP:0011915) | 2.14731521 |
| 90 | Alkalosis (HP:0001948) | 2.14410733 |
| 91 | Pigmentary retinal degeneration (HP:0001146) | 2.13078974 |
| 92 | Progressive macrocephaly (HP:0004481) | 2.12899604 |
| 93 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.12282902 |
| 94 | Spontaneous abortion (HP:0005268) | 2.10990292 |
| 95 | Hydroxyprolinuria (HP:0003080) | 2.09883912 |
| 96 | Abnormality of proline metabolism (HP:0010907) | 2.09883912 |
| 97 | Chronic hepatic failure (HP:0100626) | 2.07579416 |
| 98 | Hyperventilation (HP:0002883) | 2.07326721 |
| 99 | Generalized aminoaciduria (HP:0002909) | 2.06526694 |
| 100 | Neuroendocrine neoplasm (HP:0100634) | 2.06292225 |
| 101 | Axonal loss (HP:0003447) | 2.05571386 |
| 102 | Hyperphosphaturia (HP:0003109) | 2.05509694 |
| 103 | Abnormality of the gallbladder (HP:0005264) | 2.04698342 |
| 104 | Neonatal onset (HP:0003623) | 2.03770957 |
| 105 | Mesangial abnormality (HP:0001966) | 2.03512153 |
| 106 | Cerebral hemorrhage (HP:0001342) | 2.03466530 |
| 107 | Hepatocellular necrosis (HP:0001404) | 2.01209832 |
| 108 | Abnormal drinking behavior (HP:0030082) | 2.00543689 |
| 109 | Polydipsia (HP:0001959) | 2.00543689 |
| 110 | Pancreatitis (HP:0001733) | 2.00021766 |
| 111 | Reduced antithrombin III activity (HP:0001976) | 1.99016649 |
| 112 | Hypothermia (HP:0002045) | 1.96544516 |
| 113 | Abnormality of the renal cortex (HP:0011035) | 1.96189296 |
| 114 | Lactic acidosis (HP:0003128) | 1.95861599 |
| 115 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.95059612 |
| 116 | 3-Methylglutaconic aciduria (HP:0003535) | 1.94340739 |
| 117 | Opisthotonus (HP:0002179) | 1.94029879 |
| 118 | Abnormality of the prostate (HP:0008775) | 1.93907495 |
| 119 | Spastic paraparesis (HP:0002313) | 1.93480122 |
| 120 | Hemorrhage of the eye (HP:0011885) | 1.92117281 |
| 121 | Hepatocellular carcinoma (HP:0001402) | 1.90854868 |
| 122 | Gingival bleeding (HP:0000225) | 1.90601675 |
| 123 | Attenuation of retinal blood vessels (HP:0007843) | 1.88946697 |
| 124 | Brushfield spots (HP:0001088) | 1.87262840 |
| 125 | Spastic diplegia (HP:0001264) | 1.87248820 |
| 126 | Mitochondrial inheritance (HP:0001427) | 1.87043300 |
| 127 | Hypoglycemic seizures (HP:0002173) | 1.86960360 |
| 128 | Purpura (HP:0000979) | 1.86637658 |
| 129 | Late onset (HP:0003584) | 1.86110853 |
| 130 | Methylmalonic aciduria (HP:0012120) | 1.85791930 |
| 131 | Skin nodule (HP:0200036) | 1.85560943 |
| 132 | Increased IgM level (HP:0003496) | 1.84365538 |
| 133 | Oral leukoplakia (HP:0002745) | 1.84271010 |
| 134 | Abnormality of the axillary hair (HP:0100134) | 1.84054639 |
| 135 | Abnormality of secondary sexual hair (HP:0009888) | 1.84054639 |
| 136 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.81486934 |
| 137 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.81486934 |
| 138 | CNS demyelination (HP:0007305) | 1.81407921 |
| 139 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.80891763 |
| 140 | Hyperuricemia (HP:0002149) | 1.80582502 |
| 141 | Increased purine levels (HP:0004368) | 1.80582502 |
| 142 | Myocardial infarction (HP:0001658) | 1.80469703 |
| 143 | Abnormal urine output (HP:0012590) | 1.80082053 |
| 144 | Hypophosphatemic rickets (HP:0004912) | 1.79535667 |
| 145 | Enlarged kidneys (HP:0000105) | 1.79143073 |
| 146 | Increased serum lactate (HP:0002151) | 1.78143397 |
| 147 | Cystic liver disease (HP:0006706) | 1.77835410 |
| 148 | Anorexia (HP:0002039) | 1.77520556 |
| 149 | Parakeratosis (HP:0001036) | 1.77028414 |
| 150 | Hypochromic anemia (HP:0001931) | 1.76435827 |
| 151 | Pustule (HP:0200039) | 1.75728806 |
| 152 | Stomatitis (HP:0010280) | 1.73513067 |
| 153 | Woolly hair (HP:0002224) | 1.72240015 |
| 154 | Methylmalonic acidemia (HP:0002912) | 1.72103641 |
| 155 | Pulmonary embolism (HP:0002204) | 1.69931547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.96907347 |
| 2 | TLK1 | 3.57994383 |
| 3 | MAP4K2 | 3.51881622 |
| 4 | VRK2 | 2.67844821 |
| 5 | LMTK2 | 2.60011350 |
| 6 | MAP4K1 | 2.49883581 |
| 7 | ERN1 | 2.44272399 |
| 8 | ERBB4 | 2.34973677 |
| 9 | MAP2K4 | 2.21438047 |
| 10 | STK39 | 2.14756674 |
| 11 | TXK | 2.13664549 |
| 12 | MAP3K12 | 2.05460515 |
| 13 | ARAF | 2.04660873 |
| 14 | CASK | 2.00261396 |
| 15 | SIK1 | 1.99765330 |
| 16 | OXSR1 | 1.93046625 |
| 17 | NUAK1 | 1.91650125 |
| 18 | PIK3CA | 1.91404153 |
| 19 | GRK1 | 1.89367075 |
| 20 | MST4 | 1.79605833 |
| 21 | ZAK | 1.79210149 |
| 22 | FGFR4 | 1.78686321 |
| 23 | MUSK | 1.77212522 |
| 24 | PDK3 | 1.69840997 |
| 25 | PDK4 | 1.69840997 |
| 26 | WNK4 | 1.68127163 |
| 27 | IKBKB | 1.67571437 |
| 28 | DAPK2 | 1.67153549 |
| 29 | NTRK1 | 1.56081181 |
| 30 | CAMKK2 | 1.54722722 |
| 31 | WNK3 | 1.50608505 |
| 32 | MYLK | 1.49850664 |
| 33 | CDK19 | 1.43027626 |
| 34 | EPHB1 | 1.39027567 |
| 35 | KDR | 1.35760357 |
| 36 | SGK494 | 1.34685022 |
| 37 | SGK223 | 1.34685022 |
| 38 | MST1R | 1.32790491 |
| 39 | LIMK1 | 1.31875388 |
| 40 | STK16 | 1.29522531 |
| 41 | NEK9 | 1.26173404 |
| 42 | ACVR1B | 1.21553144 |
| 43 | MAP2K7 | 1.21394491 |
| 44 | CAMK2G | 1.19917291 |
| 45 | SYK | 1.17764244 |
| 46 | TNK2 | 1.14554614 |
| 47 | GRK6 | 1.12565963 |
| 48 | TYK2 | 1.12547747 |
| 49 | MAP2K1 | 1.12132952 |
| 50 | TESK1 | 1.10943798 |
| 51 | PDK2 | 1.10640254 |
| 52 | INSRR | 1.10599287 |
| 53 | CSF1R | 1.08507883 |
| 54 | GRK5 | 1.07920154 |
| 55 | EPHA4 | 1.04994995 |
| 56 | KIT | 1.03763199 |
| 57 | ABL2 | 1.00688291 |
| 58 | MAP3K2 | 0.97473873 |
| 59 | KSR2 | 0.96383481 |
| 60 | MINK1 | 0.94534627 |
| 61 | MAP3K4 | 0.92757518 |
| 62 | PTK2B | 0.92620945 |
| 63 | ITK | 0.92545682 |
| 64 | PHKG2 | 0.91810515 |
| 65 | PHKG1 | 0.91810515 |
| 66 | MAPK13 | 0.91276201 |
| 67 | BCR | 0.91046393 |
| 68 | MAP3K11 | 0.90350162 |
| 69 | PIM2 | 0.89898229 |
| 70 | VRK1 | 0.89682373 |
| 71 | IKBKE | 0.88832072 |
| 72 | ROCK2 | 0.88340060 |
| 73 | DYRK2 | 0.87744856 |
| 74 | GRK7 | 0.86046716 |
| 75 | TRIB3 | 0.85000052 |
| 76 | PINK1 | 0.84826093 |
| 77 | RIPK4 | 0.84290789 |
| 78 | BMPR2 | 0.83883497 |
| 79 | FRK | 0.82332806 |
| 80 | EPHB2 | 0.81658702 |
| 81 | MET | 0.81552932 |
| 82 | SIK2 | 0.80263718 |
| 83 | PASK | 0.78873199 |
| 84 | JAK3 | 0.78245825 |
| 85 | CSNK1A1L | 0.77272974 |
| 86 | PRKCG | 0.77013666 |
| 87 | CAMKK1 | 0.76261424 |
| 88 | CAMK2A | 0.76101817 |
| 89 | CCNB1 | 0.75115617 |
| 90 | CAMK2B | 0.74179175 |
| 91 | RET | 0.73477710 |
| 92 | FGR | 0.72835338 |
| 93 | MAPK4 | 0.72584264 |
| 94 | LCK | 0.69101680 |
| 95 | LYN | 0.68965952 |
| 96 | CAMK2D | 0.68698543 |
| 97 | MAP2K2 | 0.68621197 |
| 98 | TESK2 | 0.68473160 |
| 99 | SGK2 | 0.67996087 |
| 100 | BMPR1B | 0.67705207 |
| 101 | PAK3 | 0.67551351 |
| 102 | PRKD3 | 0.67057594 |
| 103 | CSNK1G3 | 0.65803197 |
| 104 | PRKCZ | 0.65687593 |
| 105 | MAP2K6 | 0.65535810 |
| 106 | FGFR2 | 0.65477367 |
| 107 | TEC | 0.63516463 |
| 108 | ERBB2 | 0.63040125 |
| 109 | PRKCQ | 0.63001681 |
| 110 | EPHA2 | 0.61987723 |
| 111 | FER | 0.61545577 |
| 112 | EPHA3 | 0.60948488 |
| 113 | MAPK15 | 0.60722700 |
| 114 | PLK2 | 0.60454551 |
| 115 | MAPK12 | 0.60241792 |
| 116 | GSK3A | 0.60189421 |
| 117 | ADRBK1 | 0.59118561 |
| 118 | CSNK1G1 | 0.59012219 |
| 119 | NME1 | 0.58598769 |
| 120 | MAPK11 | 0.58542636 |
| 121 | TAOK3 | 0.58419179 |
| 122 | ZAP70 | 0.58013838 |
| 123 | CSNK1G2 | 0.57657147 |
| 124 | PTK2 | 0.57643455 |
| 125 | TBK1 | 0.57070378 |
| 126 | PRKCE | 0.56290271 |
| 127 | STK38L | 0.56178045 |
| 128 | MAPKAPK5 | 0.56051219 |
| 129 | PRKACG | 0.55723338 |
| 130 | MAPKAPK3 | 0.55330780 |
| 131 | ROCK1 | 0.54434252 |
| 132 | MAP3K7 | 0.54181088 |
| 133 | BLK | 0.53500963 |
| 134 | ADRBK2 | 0.53380060 |
| 135 | RPS6KA5 | 0.53142766 |
| 136 | PIK3CG | 0.51683987 |
| 137 | CHUK | 0.51021899 |
| 138 | PDPK1 | 0.50784248 |
| 139 | PRKACA | 0.50724080 |
| 140 | NTRK2 | 0.50241175 |
| 141 | SGK3 | 0.50077720 |
| 142 | MAP3K1 | 0.49707515 |
| 143 | PRKCI | 0.49687872 |
| 144 | BRAF | 0.49538371 |
| 145 | PRKG2 | 0.49472186 |
| 146 | PRKCA | 0.49366667 |
| 147 | MAP3K3 | 0.49272613 |
| 148 | PTK6 | 0.49072703 |
| 149 | MOS | 0.48922817 |
| 150 | IRAK4 | 0.48887668 |
| 151 | BTK | 0.47063781 |
| 152 | PRKAA2 | 0.46701916 |
| 153 | TGFBR2 | 0.46491376 |
| 154 | ABL1 | 0.42633677 |
| 155 | IGF1R | 0.40459279 |
| 156 | FES | 0.36113027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.64791613 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.28749653 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.06530420 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.91947196 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.73085298 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.51459615 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.49843624 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.37417671 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33729480 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.24575752 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.22527404 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.22371990 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.21914824 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.13165551 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10840555 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.01760898 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.00840886 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.00809421 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.95246602 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.90375218 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87867890 |
| 22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.86907598 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.85525850 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.84770840 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.82818095 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77791410 |
| 27 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.69626798 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.69094714 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.61028948 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.50499393 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.47990133 |
| 32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.47369270 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.45816876 |
| 34 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.45810912 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.44844128 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.41281444 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.40535265 |
| 38 | Asthma_Homo sapiens_hsa05310 | 1.40121979 |
| 39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.38865648 |
| 40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.34468127 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.34394476 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31887606 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.29138077 |
| 44 | Allograft rejection_Homo sapiens_hsa05330 | 1.28943256 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.27109487 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.26857980 |
| 47 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.26748872 |
| 48 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.26291062 |
| 49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.26121001 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.25659775 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20728885 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15983519 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15733628 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.14495927 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.11190843 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08706427 |
| 57 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.02323322 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.99986384 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.98594195 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98040595 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.96400165 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.95328477 |
| 63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.91765539 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.90358938 |
| 65 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.87169682 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84987135 |
| 67 | Proteasome_Homo sapiens_hsa03050 | 0.82663452 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81600538 |
| 69 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.81195920 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80862146 |
| 71 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.78455879 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.77218972 |
| 73 | Phototransduction_Homo sapiens_hsa04744 | 0.76595372 |
| 74 | Ribosome_Homo sapiens_hsa03010 | 0.76590323 |
| 75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76267164 |
| 76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75145443 |
| 77 | Parkinsons disease_Homo sapiens_hsa05012 | 0.73283087 |
| 78 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.71455014 |
| 79 | RNA polymerase_Homo sapiens_hsa03020 | 0.70974393 |
| 80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.70457215 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67936899 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61026220 |
| 83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58692573 |
| 84 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58592495 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56978855 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.56905510 |
| 87 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55664134 |
| 88 | Alzheimers disease_Homo sapiens_hsa05010 | 0.52953126 |
| 89 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51907826 |
| 90 | Protein export_Homo sapiens_hsa03060 | 0.51625198 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.46613227 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46203932 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45361321 |
| 94 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44902991 |
| 95 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.43383199 |
| 96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.41987935 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40084304 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37966955 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.35815371 |
| 100 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34716391 |
| 101 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.34606103 |
| 102 | Huntingtons disease_Homo sapiens_hsa05016 | 0.28258267 |
| 103 | Pertussis_Homo sapiens_hsa05133 | 0.28100233 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25911774 |
| 105 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.24647692 |
| 106 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.23795390 |
| 107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.23380526 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.21950001 |
| 109 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.19691167 |
| 110 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.15819471 |
| 111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.11812775 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08629309 |
| 113 | Lysine degradation_Homo sapiens_hsa00310 | 0.06983057 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05739011 |
| 115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.05511500 |
| 116 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.04196498 |
| 117 | Lysosome_Homo sapiens_hsa04142 | 0.03841687 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.03836606 |
| 119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.02150342 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.00963803 |
| 121 | Phagosome_Homo sapiens_hsa04145 | 0.00577677 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.0204650 |
| 123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0078932 |
| 124 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.0054415 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0045951 |
| 126 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0014643 |

